Arrhythmic risk during pregnancy and postpartum in patients with long QT syndrome
Herzschrittmachertherapie + Elektrophysiologie · 2021-06 · 32 (2) · 180-185
DOI: 10.1007/s00399-021-00757-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Herzschrittmachertherapie + Elektrophysiologie, online erschienen am 29.03.2021. Verfasst von Babken Asatryan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Translational Cardiology, Department of Cardiology, Inselspital, Bern University Hospital, Freiburgstrasse 8, 3010, Bern, Switzerland. Hauptthemen laut MEDLINE: Long QT Syndrome, Torsades de Pointes. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Bern.
Abstract (Originalsprache)
Congenital long QT syndrome (LQTS) is a genetic disorder characterized by a prolonged QT interval in the surface electrocardiogram (ECG) that predisposes affected individuals to arrhythmic syncope, ventricular torsades-de-pointes, and sudden cardiac death at a young age. Investigations of large patient cohorts revealed sex-related differences in the LQTS phenotype. Adult women with LQTS are at higher risk for cardiac arrhythmias than are adult men with LQTS. Sex hormones are thought to play the primary role for these gender differences. Clinical experience and translational studies indicated that females with LQTS have a lower risk for cardiac arrhythmias during pregnancy and elevated risk in the postpartum period due to contrasting effects of estradiol and progesterone, as well as postpartum hormones on the action potential and arrhythmia substrate. However, this pro- or anti-arrhythmic potential of hormones varies depending on the underlying genotype, partly since sex hormones have distinct effects on different (affected) cardiac ion channels. Thus, a comprehensive evaluation of women with LQTS prior to and during pregnancy, during labor, and in the postpartum period with consideration of the patient’s disease- and gene-specific risk factors is essential to providing precision management in this patient group. This review discusses the current understanding of hormonal influences in LQTS and provides practical guidance for the optimal management of LQTS patients during pregnancy, delivery, and the postpartum period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Translational Cardiology, Department of Cardiology, Inselspital, Bern University Hospital, Freiburgstrasse 8, 3010, Bern, Switzerland.
- Translational Cardiology, Department of Cardiology, Inselspital, Bern University Hospital, Freiburgstrasse 8, 3010, Bern, Switzerland. katja.odening@insel.ch.
- Institute of Physiology, University of Bern, Buehlplatz 5, 3012, Bern, Switzerland. katja.odening@insel.ch.
Förderung
- University of Bern
Zitieren
APA
Asatryan, B., Rieder, M., Castiglione, A., & Odening, K. E. (2021). Arrhythmic risk during pregnancy and postpartum in patients with long QT syndrome. Herzschrittmachertherapie + Elektrophysiologie, 32(2), 180-185. https://doi.org/10.1007/s00399-021-00757-4
Vancouver
Asatryan B, Rieder M, Castiglione A, Odening KE. Arrhythmic risk during pregnancy and postpartum in patients with long QT syndrome. Herzschrittmachertherapie + Elektrophysiologie. 2021;32(2):180-185. doi:10.1007/s00399-021-00757-4
BibTeX
@article{Asatryan2021,
author = {Asatryan, Babken and Rieder, Marina and Castiglione, Alessandro and Odening, Katja E},
title = {Arrhythmic risk during pregnancy and postpartum in patients with long QT syndrome},
journal = {Herzschrittmachertherapie + Elektrophysiologie},
year = {2021},
volume = {32},
number = {2},
pages = {180--185},
doi = {10.1007/s00399-021-00757-4}
}
EUVIMED